カレントテラピー　35-3　サンプル page 12/30

このページは カレントテラピー　35-3　サンプル の電子ブックに掲載されている12ページの概要です。
秒後に電子ブックの対象ページへ移動します。
「電子ブックを開く」をクリックすると今すぐ対象ページへ移動します。

概要：
カレントテラピー　35-3　サンプル

Current Therapy 2017 Vol.35 No.3 15致死性不整脈の管理215tricular fibrillation. N Engl J Med 341：871-878, 19994）Dorian P, Cass D, Schwartz B, et al：Amiodarone as comparedwith lidocaine for shock-resistant ventricular fibrillation.N Engl J Med 346：884-890, 20025）日本蘇生協議会：JRC蘇生ガイドライン2015．（http://www.japanresuscitationcouncil.org/jrc蘇生ガイドライン2015/）（2016年12月閲覧）6）Kudenchuk PJ, Brown SP, Daya M, et al；Resuscitation OutcomesConsortium Investigators：Amiodarone, lidocaine, orplacebo in out -of -hospital cardiac arrest. N Engl J Med374：1711-1722, 20167）Reynolds JC, Frisch A, Rittenberger JC, et al：Duration ofresuscitation efforts and functional outcome after out-of-hospitalcardiac arrest：when should we change to novel therapies?Circulation 128：2488-2494, 20138）Weisfeldt ML, Becker LB：Resuscitation after cardiacarrest：a 3-phase time-sensitive model. JAMA 288：3035-3038, 20029）Cohen CJ, Spires S, Van Skiver D：Block of T-type Ca channelsin guinea pig atrial cells by antiarrhythmic agents andCa channel antagonists. J Gen Physiol 100：703-728, 199210）Tamura A, Ogura T, Uemura H, et al：Effects of antiarrhythmicdrugs on the hyperpolarization-activated cyclicnucleotide -gated channel current. J Pharmacol Sci 110：150-159, 200911）Somberg JC, Cvetanovic I, Ranade V, et al：Comparativeeffects of rapid bolus administration of aqueous amiodaroneversus 10-minute cordarone I.v. infusion on mean arterialblood pressure in conscious dogs. Cardiovasc Drugs Ther18：345-351, 200412）Katoh T, Ogawa S, Yamaguchi I, et al：Efficacy and safety ofintravenous amiodarone infusion in Japanese patients withhemodynamically compromised ventricular tachycardia orventricular fibrillation. J Arrhythmia 23：131-139, 200713）Amino M, Inokuchi S, Nagao K, et al；SOS-KANTO 2012Study Group：Nifekalant hydrochloride and amiodaronehydrochloride result in similar improvements for 24-hoursurvival in cardiopulmonary arrest patients：The SOS -KANTO 2012 Study. J Cardiovasc Pharmacol 66：600-609,201514）Amino M, Inokuchi S, Yoshioka K, et al；SOS-KANTO 2012Study Group：Does antiarrhythmic drug during cardio-pulmonaryresuscitation improve the one-month survival：TheSOS -KANTO 2012 study. J Cardiovasc Pharmacol 68：58-66, 201615）Laina A, Karlis G, Liakos A, et al：Amiodarone and cardiacarrest：Systematic review and meta-analysis. Int J Cardiol221：780-788, 201616）Amino M, Yoshioka K, Opthof T, et al：Comparative studyof nifekalant versus amiodarone for shock-resistant ventricularfibrillation in out -of -hospital cardiopulmonary arrestpatients. J Cardiovasc Pharmacol 55：391-398, 201017）Harayama N, Nihei S, Nagata K, et al：Comparison of nifekalantand amiodarone for resuscitation of out-of-hospital cardiopulmonaryarrest resulting from shock-resistant ventricularfibrillation. J Anesth 28：587-592, 201418）Sanfilippo F, Corredor C, Santonocito C, et al：Amiodaroneor lidocaine for cardiac arrest：A systematic review andmeta-analysis. Resuscitation 107：31-37, 201619）Tagami T, Matsui H, Tanaka C, et al：Amiodarone Comparedwith Lidocaine for Out -Of-Hospital Cardiac Arrestwith Refractory Ventricular Fibrillation on Hospital Arrival：a Nationwide Database Study. Cardiovasc Drugs Ther 30：485-491, 201620）Tagami T, Matsui H, Ishinokami S, et al：Amiodarone ornifekalant upon hospital arrival for refractory ventricularfibrillation after out-of-hospital cardiac arrest. Resuscitation109：127-132, 2016